November 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreMarch 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreOctober 14, 2025
According to market projections, the global blockchain in healthcare market, valued at USD 1.37 billion in 2024, is anticipated to reach USD 25.52 billion by 2034, growing at a CAGR of 34.02% over the next decade. Technological advancements, burgeoning healthcare sector, and demand for improved patient outcomes drive the market....
October 14, 2025
The global over-the-counter (OTC) analgesic market, valued at USD 30.61 billion in 2024, is anticipated to reach USD 44.02 billion by 2034, growing at a CAGR of 3.7% over the next decade. An over-the-counter (OTC) analgesic is a pain-relieving medicine you can buy without a prescription. It helps reduce pain, fever, or inflammation and includes com...
October 14, 2025
The inhaled therapy in respiratory disease market is valued at USD 11.98 billion in 2025 and expected to reach USD 16.22 billion by 2034 at 3.44% CAGR. Dominant segments include bronchodilators (28%), MDIs (35%), COPD (38%), retail pharmacies (60%), and inhaled biologics growing fastest. North America holds 42% share, Asia Pacific fastest-growing. ...
October 14, 2025
The global marine pharmaceuticals market was valued at USD 6.19 B in 2024 and is projected to reach USD 10.34 B by 2034 at a 5.29% CAGR. Covers NA, EU, APAC, LA, MEA, with full segmentation, trade, manufacturer, and supplier data. Regional data across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa is presente...
October 14, 2025
According to forecasts, the global berberine API market will grow from USD 523 million in 2024 to USD 973.13 million by 2034, with an expected CAGR of 6.45%.The berberine API market is growing due to its wide use in nutraceuticals, pharmaceuticals, and health supplements, as it has a wide range of pharmacological effects. Asia Pacific is dominant i...
October 14, 2025
According to market projections, the gene therapies for cancer treatment sector is expected to grow from USD 8.28 billion in 2024 to USD 238.77 billion by 2034, reflecting a CAGR of 39.94%. The rising prevalence of cancer and the growing demand for personalized medicines drive the global market. North America dominated due to the availability of st...
October 13, 2025
Projections indicate that, travel vaccination service industry is projected to rise from USD 4.69 billion in 2024 to USD 11.99 billion by 2034, reflecting a CAGR of 9.85% over the next decade. The rising prevalence of infectious disorders and increasing international travel bolster market growth. Favorable government support and a robust healthcare...
October 13, 2025
According to forecasts, the Europe cell and gene therapy market will grow from USD 2.74 billion in 2024 to USD 48.96 billion by 2034, with an expected CAGR of 23.90%. The Europe cell and gene therapy market is growing due to the growing incidence of genetic diseases and enhanced regulatory frameworks....
October 13, 2025
According to forecasts, the North America cell and gene therapy market will grow from USD 9.19 billion in 2024 to USD 79.01 billion by 2034, with an expected CAGR of 24.01%. The North America cell and gene therapy market is growing due to the rising demand for highly specific therapeutics for genetic disorders....
October 13, 2025
The cell and gene therapy infrastructure market is growing due to advances in gene editing technology and the increasing prevalence of genetic and chronic diseases. North America is dominant in the market due to the robust public and private spending....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com